Back | Next |
home / stock / kdmn / kdmn message board
Subject | By | Source | When |
---|---|---|---|
Added 3500 near the close. | farooq | investorshub | 07/27/2021 2:58:16 AM |
12,700...and my rosary beads | saigai | investorshub | 07/22/2021 4:05:57 PM |
Added today 3.77 to 3.83 now total 26000 | farooq | investorshub | 07/22/2021 3:59:35 PM |
You must be short. | farooq | investorshub | 07/22/2021 3:55:18 PM |
2500 right here | saigai | investorshub | 07/20/2021 5:19:05 PM |
This one sure slipped through the radar... everyone | Johnstonj27 | investorshub | 07/17/2021 1:23:19 AM |
Fake News! Lolzzzz | SurgeGuy2.0 | investorshub | 07/16/2021 10:35:26 PM |
I am in from 3.57 for 7300 shares, | farooq | investorshub | 07/16/2021 8:39:11 PM |
Approved..Congrats! | bUrRpPPP! | investorshub | 07/16/2021 8:37:42 PM |
And now the MM's are crashing it... | Johnstonj27 | investorshub | 07/16/2021 8:31:08 PM |
wow, should held till afterhours they turned the | Johnstonj27 | investorshub | 07/16/2021 8:03:24 PM |
Wow was scheduled for Aug 30 Date and | Johnstonj27 | investorshub | 07/16/2021 7:33:19 PM |
Send it.... | Johnstonj27 | investorshub | 07/16/2021 7:20:45 PM |
FDA APPROVAL... halt is OFF | Johnstonj27 | investorshub | 07/16/2021 7:20:05 PM |
BOOM FDA | Johnstonj27 | investorshub | 07/16/2021 7:18:49 PM |
whytestocks: $KDMN News Article - U.S. FDA Grants Full Approval of REZUROCK(TM) (belumosudil) for th | whytestocks | investorshangout | 07/16/2021 6:25:50 PM |
whytestocks: $KDMN News Article - Kadmon Announces Publication of Phase 2a Clinical Trial Results of | whytestocks | investorshangout | 04/21/2021 12:15:52 PM |
whytestocks: $KDMN News Article - KDMN BREAKING NEWS: ROSEN, A TOP RANKED LAW FIRM, Encourages Kadmo | whytestocks | investorshangout | 04/05/2021 7:45:50 PM |
whytestocks: $KDMN News Article - Kadmon Announces Trial-In-Progress Poster on KD033 at the 2021 Ame | whytestocks | investorshangout | 03/25/2021 4:25:50 PM |
Adding | Pennybuster | investorshub | 02/19/2021 2:15:00 AM |
News, Short Squeeze, Breakout and More Instantly...
Kadmon Holdings Inc. Company Name:
KDMN Stock Symbol:
NYSE Market:
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadm...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kadmon Holdings, Inc. Skyrockets Amid Entering Definitive Merger Agreement with Sanofi Kadmon Holdings, Inc. (NASDAQ: KDMN) surged 73% in premarket trading after entering...